HSS Journal

, Volume 2, Issue 2, pp 198–201 | Cite as

Conflict of Interest

  • C. Ronald MacKenzieEmail author
  • Bruce N. Cronstein

Conflict of interest refers to a “a set of conditions in which professional judgment concerning a primary interest (such as a patient's welfare or the validity of research) is unduly influenced by a secondary interest (such as financial gain) [1].” Although most of the literature and commentary on this subject have focused on financial considerations, these are not the only interests that may affect physician behavior. Other potent influences include the desire for professional recognition and promotion, the ability to successfully compete for funding in the research environment, a physician's interest in the patient's well-being (in contrast to that of the community or employer), or even simply the quest for knowledge. Over the last two decades, complex relationships between industry, investigators, and academic institutions have evolved inevitably resulting in various ethical challenges. In this paper, we present an overview of the problems arising from such interactions and...


Medical Education Academic Medical Center Continue Medical Education Potential Conflict Professional Judgment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Thompson D (1993) Understanding financial conflicts of interest. N Engl J Med 329:573–576PubMedCrossRefGoogle Scholar
  2. 2.
    Ramsey P (1970) The patient as person. Yale University Press, New Haven, CTGoogle Scholar
  3. 3.
    Beachamp TL, Childress JF (2001) Principles of biomedical ethics, 5th edn. Oxford University Press, New York, NYGoogle Scholar
  4. 4.
    Barnes M, Florencio P (2002) Financial conflicts of interest in human subjects research: the problem of institutional conflicts. J Law Med Ethics 30:1–13CrossRefGoogle Scholar
  5. 5.
    Hillman AI, Pauly MV, Kerslein B (1989) How do financial incentives affect physician's clinical decisions and the financial performance of health maintenance organizations. N Engl J Med 321:86–92PubMedCrossRefGoogle Scholar
  6. 6.
    Hillman BJ et al (1990) Frequency and costs of diagnostic imaging in office practice: comparison of self-referring and radiologist referring physicians. N Engl J Med 323:1604–1608PubMedCrossRefGoogle Scholar
  7. 7.
    Swerdlow A et al (1992) Increased costs and rates of use in the California workers' compensation system as a result of self-referral by physicians. N Engl J Med 327:1502–1506CrossRefGoogle Scholar
  8. 8.
    Wilkinson P (1993) Self-referral: a potential conflict of interest. Br Med J 1083–1084Google Scholar
  9. 9.
    Chren MM, Landenfeld CS (1994) Physicians behavior and their interactions with drug companies: a controlled study of physicians who request additions to a hospital formulary. JAMA 271:684–689PubMedCrossRefGoogle Scholar
  10. 10.
    Wazana A (2000) Physicians and the pharmaceutical industry: is a gift just ever a gift? JAMA 283:373–380PubMedCrossRefGoogle Scholar
  11. 11.
    Kassirer (2000) A piece of my mind: financial indigestion. JAMA 284:2156–2157PubMedCrossRefGoogle Scholar
  12. 12.
    Rothman DJ (2000) Medical professionalism—focusing on the real issues. NEJM 342:1284–1286PubMedCrossRefGoogle Scholar
  13. 13.
    Waud DR (1992) Pharmaceutical promotions—a free lunch. NEJM 327:684–689Google Scholar
  14. 14.
    Andaleeb SS, Tallman RF (1995) Physician attitudes toward pharmaceutical sales representatives. Health Care Manage Rev 20:68–76PubMedGoogle Scholar
  15. 15.
    Thomson AN, Craig BJ, Barham PM (1994) Attitudes of general practitioners in New Zealand to pharmaceutical representatives. Br J Gen Pract 44:220–223PubMedGoogle Scholar
  16. 16.
    Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research. JAMA 289:454–465PubMedCrossRefGoogle Scholar
  17. 17.
    Bayh–Dole Act, Pub L No. 96-517, 35 USC (1980)Google Scholar
  18. 18.
    Korn D (2000) Conflicts of interest in biomedical research. JAMA 284:2234–2237PubMedCrossRefGoogle Scholar
  19. 19.
    Stolberg SG (1999) The biotech death of Jesse Gelsinger. New York Times Magazine, 28 Nov 1999Google Scholar
  20. 20.
    Beardsley T (2000) Gene therapy setback: a tragic death clouds the future of an innovative treatment method. Sci Am 282:36–37PubMedCrossRefGoogle Scholar
  21. 21.
    Topol EJ, Blumenthal D (2005) Physicians and the investment industry. JAMA 293:2645–2657Google Scholar
  22. 22.
    Association of American Universities (2001) Task Force Report on Individual and Institutional Conflicts of Interest, Association of American Universities, Washington, DC, October, pp 1–22, at 10. Available at
  23. 23.
    Armstrong D (2005) The Wall Street Journal. 12 Dec 2005Google Scholar
  24. 24.
    International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Nov 2001:
  25. 25.
    The Editors (2004) The Lancet's policy on conflicts of interest—2004. The Lancet 363:2–3CrossRefGoogle Scholar
  26. 26.
    The Editors (2002) Financial associations of authors. NEJM 346:1901–1902CrossRefGoogle Scholar

Copyright information

© Hospital for Special Surgery 2006

Authors and Affiliations

  1. 1.Department of Clinical Medicine and Public Health (Medical Ethics)Hospital for Special Surgery, Weill Medical College of Cornell UniversityNew YorkUSA
  2. 2.Division of Clinical Pharmacology, Department of MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations